Fasciola hepatica: Life Cycle, Pathogenesis, and Laboratory Diagnosis

A woman comes to the clinic with weeks of pain under her right ribs, on and off fever, and a general feeling of being unwell. Her liver is enlarged and tender. A blood count shows a striking rise in eosinophils. The picture looks like a liver abscess or even a tumor, and imaging shows tracks running through the liver tissue. But the stool is repeatedly negative for any parasite. She had eaten wild watercress gathered from a hillside stream some weeks earlier.

The stool is negative for a reason that is central to understanding this parasite. The worm causing her illness is still young, still tunneling through the liver on its way to the bile ducts, and it has not yet begun to lay eggs. This gap between the illness and the appearance of eggs is one of the defining features of Fasciola hepatica. This article explains the journey the fluke makes, why the disease comes in two distinct phases, how the egg is finally found, and why this fluke is treated with a different drug from most others.

What Is Fasciola hepatica?

Fasciola hepatica is a large, leaf-shaped trematode known as the common liver fluke or the sheep liver fluke. The adult worm lives in the bile ducts of the liver, in humans and, far more commonly, in sheep, cattle, goats, and other plant-eating animals. The disease it causes is called fascioliasis. A closely related species, Fasciola gigantica, is mainly a parasite of animals in parts of Africa and Asia but can also infect people; the clinical picture is treated as essentially the same.

Two features set Fasciola apart from the other liver flukes and explain most of what follows.

1. First, humans are infected by eating plants, not fish. The infective larva encysts on aquatic vegetation, most famously wild watercress, and also reaches people through water used for drinking or for washing vegetables. This plant-and-water route separates Fasciola from the fish-borne liver flukes (Clonorchis, Opisthorchis), which share the same final home in the biliary tree but a completely different mode of acquisition.
2. Second, the adult worms are large and they migrate through the liver to reach the bile ducts. The other liver flukes are small and travel to the bile ducts by a short route up the bile duct opening. Fasciola larvae take the long way: they bore out of the intestine, cross the abdominal cavity, and tunnel through the substance of the liver itself. That destructive migration is the source of the acute-phase illness.

Life Cycle

The life cycle of Fasciola runs between a mammal (the definitive host, usually a grazing animal, sometimes a human) and a freshwater snail, and it is completed on a plant.

1. Eggs pass in the stool. Adult flukes in the bile ducts release eggs, which travel down the bile into the intestine and out in the feces. The eggs are passed unembryonated, meaning the larva inside is not yet formed.
2. Development in water. In fresh water the egg develops over roughly two weeks and releases a swimming larva, the miracidium.
3. Snail stage. The miracidium enters a suitable freshwater snail. Inside the snail the parasite multiplies through several stages and eventually releases free-swimming cercariae.
4. Encystment on plants. The cercariae leave the snail, swim briefly, and settle on aquatic plants such as watercress, where each encysts into a tough resting form called a metacercaria. This is the infective stage.
5. Human infection. A person is infected by eating the raw plant carrying metacercariae, or by drinking contaminated water. The metacercaria excysts in the small intestine.
6. Migration through the liver. The young fluke bores through the intestinal wall into the abdominal cavity, penetrates the liver capsule, and tunnels through the liver tissue for several weeks. It finally reaches the bile ducts, matures into an adult, and begins to lay eggs. In humans, this journey from swallowed metacercaria to egg-laying adult takes about three to four months.

Two consequences of this cycle are worth fixing in memory. The infective stage sits on a plant, not in a fish or a crab, which is unique among the liver flukes. And the long migration through liver tissue, absent in the other liver flukes, is what produces the distinctive acute illness.

Pathogenesis

Fascioliasis is best understood as two illnesses in sequence, because the young migrating fluke and the settled adult fluke cause completely different problems. This two-phase structure is the key to the whole topic.

The acute (migratory) phase. This phase corresponds to the young fluke boring through the liver. As it tunnels, it destroys liver tissue, provokes inflammation, and triggers a strong allergic response. The result is right upper abdominal pain, fever, malaise, nausea, an enlarged and tender liver, and, characteristically, a marked rise in eosinophils in the blood. Imaging may show tracks or nodules in the liver where the fluke has migrated. This phase begins within days to weeks of eating the metacercariae and can last for months. Crucially, no eggs are being produced yet, so stool examination is negative during this phase.

The chronic (biliary) phase. Once the fluke reaches the bile ducts and matures, the illness changes character. The adult worms in the bile ducts cause inflammation, thickening, and obstruction. Some patients are without symptoms for months or years. Others develop the picture of biliary disease: intermittent pain, inflammation of the bile ducts (cholangitis), blockage, gallstones, and sometimes jaundice. Eosinophilia is usually milder in this phase than in the acute phase. It is only now, in the chronic phase, that eggs appear in the stool.

One number worth knowing. Fasciola does not multiply inside the human host. Every adult fluke came from a separate swallowed metacercaria. This means the severity of disease depends on how many infective larvae were eaten (the inoculum), not on any multiplication inside the body. It also stands in contrast to Schistosoma, where a single infection produces enormous numbers of eggs internally. The size of the fluke matters too: these are large worms, and even a modest number can block a bile duct.

The chain to memorize: swallowed on a plant, larva tunnels through liver (acute phase, pain and eosinophilia, no eggs yet), adult settles in bile duct (chronic phase, obstruction, eggs finally appear).

Ectopic Disease and a Historical Oddity

Occasionally the migrating larvae wander to sites other than the liver, called ectopic sites, including the skin and subcutaneous tissue, lungs, or elsewhere; a worm may even work its way out through the skin. These presentations are uncommon but explain otherwise puzzling cases.

A historical curiosity worth a line is Halzoun, a syndrome of the throat and upper airway reported in the Middle East after eating raw or undercooked sheep or goat liver, once attributed to young Fasciola flukes attaching in the pharynx. Whether Fasciola or other agents cause it remains unsettled, but it is a memorable link between the parasite and the practice of eating raw liver.

Laboratory Diagnosis

Diagnosing fascioliasis requires suspicion, because the acute illness is nonspecific and the laboratory tools each have a blind spot. The central problem is timing: the patient is often sickest in the acute phase, but eggs do not appear until the chronic phase, three to four months later.

Finding the egg. The standard confirming test is microscopic detection of Fasciola eggs in stool, or in fluid aspirated from the duodenum or bile ducts. Because egg output can be low and intermittent, more than one stool sample is often needed. The Fasciola egg is large (about 130 to 150 µm long by 60 to 90 µm wide), oval, and operculated, with a small lid at one end, and it is passed unembryonated. Its large size and operculum place it firmly in the group of large operculated fluke eggs.

The lookalike that changes treatment. Fasciola eggs are very difficult to tell apart from the eggs of Fasciolopsis buski, a large intestinal fluke, on shape and size alone. This is not a minor academic point: the two flukes are treated with different drugs, so mistaking one for the other can lead to the wrong treatment. For how the large operculated eggs are approached side by side, see the comparison in the trematodes overview page.

Serology fills the timing gap. Because antibodies to Fasciola become detectable within about two to four weeks of infection, well before eggs appear, blood tests are especially useful in the acute phase, in light chronic infections with scanty eggs, and in ectopic infection where no eggs reach the stool. A limitation is that antibody tests cannot separate a past infection from a current one.

Imaging and supportive findings. Ultrasound, CT, or MRI can show the migratory tracks in the liver in the acute phase, or dilated bile ducts containing flukes in the chronic phase, and endoscopic examination of the bile ducts can both show and sometimes remove adult worms. Eosinophilia is a strong supportive clue, most marked in the acute phase.

The pseudofascioliasis trap. Eating the infected liver of a sheep or cow can pass Fasciola eggs straight through the human gut and into the stool without any true infection. These are spurious eggs, not evidence of disease. If this is suspected, the person avoids liver in the diet for several days and the stool examination is repeated; serology can also help settle the question. This is a classic examination trap and a real laboratory pitfall.

Treatment

The drug of choice for fascioliasis is triclabendazole, which is active against both the immature migrating flukes and the mature adults. This activity against the migrating stage matters, because it means the acute phase can be treated, unlike some antiparasitic drugs that only reach the adult worm.

One point is essential and is the reason the egg lookalike matters so much: praziquantel, the workhorse drug for most flukes and for schistosomes, does not work against Fasciola. A patient whose Fasciola infection is mistaken for another fluke and treated with praziquantel will not be cured. This single fact ties the microscope to the clinic: getting the egg identification right changes the drug.

How to Remember

• Two phases, two diseases. Young fluke tunneling through liver equals the acute phase: pain, fever, big eosinophil count, and no eggs yet. Adult fluke in the bile duct equals the chronic phase: obstruction and, at last, eggs in stool. If you hold the two phases apart, every symptom and every test result falls into place.
• Watercress, not fish. Fasciola rides in on a plant. That one word separates it from the fish-borne liver flukes (Clonorchis, Opisthorchis) that end up in the same bile ducts by a different road.
• The egg arrives late. The patient can be ill for months before the first egg appears, because the fluke has to finish its migration and mature first. When stool is negative but the story fits, think acute-phase Fasciola and reach for serology.
• Triclabendazole, not praziquantel. This is the fluke that breaks the praziquantel rule. Remember it as the exception: for Fasciola, the answer is triclabendazole, and praziquantel fails.
• It does not multiply in you. However many flukes you have, that is how many metacercariae were swallowed. No internal multiplication, unlike Schistosoma.

Key Exam Facts

Where Students Get Confused

Negative stool does not mean no infection. This is the single most important trap. During the acute phase, which is often when the patient is most unwell, the fluke has not started laying eggs, so stool is negative. Eggs appear only after about three to four months, in the chronic phase. If the clinical story fits acute fascioliasis, a negative stool should prompt serology, not reassurance.

Fasciola and Fasciolopsis eggs look alike but are treated differently. The eggs of Fasciola hepatica (a liver fluke) and Fasciolopsis buski (an intestinal fluke) overlap so closely in size and shape that they can be very hard to separate under the microscope. The old teaching that a roughened area at one end of the Fasciola egg reliably distinguishes them does not hold up, because that feature varies by population. The reason this matters is treatment: praziquantel treats Fasciolopsis but not Fasciola. Getting the identification wrong can mean giving a drug that will not cure the patient.

Fasciola is a liver fluke, but not a fish-borne one. Students group all the liver flukes together and assume they are all caught from raw fish. Clonorchis and Opisthorchis are fish-borne, but Fasciola is acquired from water plants and contaminated water. Same final organ, different source. The food history is the fastest way to separate them.

The praziquantel exception. Praziquantel is so widely used for flukes and schistosomes that students reach for it automatically. Fasciola is the important exception: it responds to triclabendazole, and praziquantel is not effective. This is worth memorizing as a standalone fact because it is a favorite examination point and a genuine clinical error to avoid.

Spurious eggs from eaten liver. Finding Fasciola eggs in the stool of someone who recently ate liver does not prove they are infected. The eggs may simply have passed through the gut from the meal. A liver-free diet followed by a repeat stool examination sorts this out. This is the pseudofascioliasis trap, and it appears in both examinations and real laboratory practice.

References

1. Centers for Disease Control and Prevention. DPDx: Fascioliasis. Atlanta: CDC Division of Parasitic Diseases and Malaria; last reviewed May 2, 2019. Available from: https://www.cdc.gov/dpdx/fascioliasis/index.html
2. Centers for Disease Control and Prevention. Clinical Overview of Fasciola. Atlanta: CDC National Center for Emerging and Zoonotic Infectious Diseases; last reviewed January 2, 2024. Available from: https://www.cdc.gov/liver-flukes/hcp/clinical-overview-fasciola/index.html
3. Centers for Disease Control and Prevention. About Fasciola. Atlanta: CDC National Center for Emerging and Zoonotic Infectious Diseases; last reviewed February 14, 2024. Available from: https://www.cdc.gov/liver-flukes/fasciola/index.html
4. Esteban JG, Muñoz-Antolí C, Toledo R, Ash LR. Diagnosis of human trematode infections. In: Toledo R, Fried B, editors. Digenetic Trematodes. Advances in Experimental Medicine and Biology, vol 1154. Cham: Springer; 2019. p. 437–471. Available from: https://doi.org/10.1007/978-3-030-18616-6_14
5. Garcia LS. Diagnostic Medical Parasitology. 6th ed. Washington, DC: ASM Press; 2016.
6. World Health Organization. Foodborne trematode infections. Geneva: WHO Health Topics. Available from: https://www.who.int/health-topics/foodborne-trematode-infections